Advanced Computer-Aided Drug Design Service
Dawn of Bioinformatics Ltd. delivers advanced Computer-Aided Drug Design (CADD) solutions to streamline modern drug discovery. Leveraging both ligand-based and structure-based methodologies, our DawniLab specialists systematically identify, optimize, and validate lead compounds with enhanced binding affinity, specificity, and favorable ADMET profiles. By integrating state-of-the-art computational tools, we minimize wet-lab dependency, reduce development costs, and accelerate the transition from target identification to lead optimization.
Overview
Dawn of Bioinformatics Ltd. delivers advanced Computer-Aided Drug Design (CADD) solutions to streamline modern drug discovery. Leveraging both ligand-based and structure-based methodologies, our DawniLab specialists systematically identify, optimize, and validate lead compounds with enhanced binding affinity, specificity, and favorable ADMET profiles. By integrating state-of-the-art computational tools, we minimize wet-lab dependency, reduce development costs, and accelerate the transition from target identification to lead optimization.
Key Features
• High-throughput virtual screening (HTVS) of extensive compound libraries.
• Comprehensive ADME profiling and toxicity prediction.
• Pharmacophore modeling and QSAR-based predictive analysis.
• Hit-to-lead optimization and drug-likeness evaluation.
• Protein–ligand interaction analysis and binding hotspot identification.
• Powered by industry-standard platforms (BIOVIA Discovery Studio, Schrödinger, AutoDock Vina).
Demo & Results
